Emory's Hope Clinic

Last updated

Emory's Hope Clinic
Emory Vaccine Center, Emory University
Geography
Location603 Church Street
Decatur, Georgia 30030
Organisation
Funding Government hospital
Type Teaching
Affiliated university Emory University
Services
SpecialityClinical vaccine trials
Links
Website www.hopeclinic.emory.edu

The Hope Clinic of the Emory Vaccine Center, commonly known as Emory's Hope Clinic, is the clinical trials arm of the Emory Vaccine Center that is currently located near Dekalb Medical Center in Decatur, Georgia. [1] The original Executive Director of the clinic was Dr. Mark Feinberg who lead from 2002 – 2004, followed by Dr. Carlos Del Rio from 2004 to 2006. The clinic staff consisted of an average of 10 - 15 employees during this time. Dr. Mark Mulligan became the Executive Director in 2006. As of 2022, Dr. Nadie Rouphael is the Executive Director. [2]

Since 2012, the Hope Clinic has been studying HIV-negative subjects and the effect of protein antigens on healthy immune systems. This information is being collected and studied in conjunction with finding a potential cure for HIV-positive patients using a major immune system boost. [3]

Related Research Articles

<span class="mw-page-title-main">Centers for Disease Control and Prevention</span> United States government public health agency

The Centers for Disease Control and Prevention (CDC) is the national public health agency of the United States. It is a United States federal agency under the Department of Health and Human Services, and is headquartered in Atlanta, Georgia.

<span class="mw-page-title-main">Tuberculosis</span> Infectious disease

Tuberculosis (TB) is an infectious disease usually caused by Mycobacterium tuberculosis (MTB) bacteria. Tuberculosis generally affects the lungs, but it can also affect other parts of the body. Most infections show no symptoms, in which case it is known as latent tuberculosis. Around 10% of latent infections progress to active disease which, if left untreated, kill about half of those affected. Typical symptoms of active TB are chronic cough with blood-containing mucus, fever, night sweats, and weight loss. It was historically referred to as consumption due to the weight loss associated with the disease. Infection of other organs can cause a wide range of symptoms.

<span class="mw-page-title-main">Vaccine</span> Pathogen-derived preparation that provides acquired immunity to an infectious disease

A vaccine is a biological preparation that provides active acquired immunity to a particular infectious or malignant disease. The safety and effectiveness of vaccines has been widely studied and verified. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and to further recognize and destroy any of the microorganisms associated with that agent that it may encounter in the future.

<span class="mw-page-title-main">Emory University</span> Private university in Atlanta, Georgia, United States

Emory University is a private research university in Atlanta, Georgia. Founded in 1836 as "Emory College" by the Methodist Episcopal Church and named in honor of Methodist bishop John Emory, Emory is the second-oldest private institution of higher education in Georgia.

<span class="mw-page-title-main">MMR vaccine</span> Any of several combined vaccines against measles, mumps, and rubella

The MMR vaccine is a vaccine against measles, mumps, and rubella, abbreviated as MMR. The first dose is generally given to children around 9 months to 15 months of age, with a second dose at 15 months to 6 years of age, with at least four weeks between the doses. After two doses, 97% of people are protected against measles, 88% against mumps, and at least 97% against rubella. The vaccine is also recommended for those who do not have evidence of immunity, those with well-controlled HIV/AIDS, and within 72 hours of exposure to measles among those who are incompletely immunized. It is given by injection.

The National Institute of Allergy and Infectious Diseases is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

<span class="mw-page-title-main">Julie Gerberding</span> American physician, educator, infectious disease specialist

Julie Louise Gerberding is an American infectious disease expert who was the first woman to serve as the director of the U.S. Centers for Disease Control and Prevention (CDC). As of May 2022, she is the CEO of the Foundation for the National Institutes of Health (FNIH). Gerberding grew up in Estelline, South Dakota, attended Brookings High School, and earned undergraduate and graduate degrees from Case Western Reserve University. She was the chief medical resident at the University of California, San Francisco where she treated hospitalized AIDS patients in the first years of the epidemic. Gerberding became a nationally-recognized figure during the 2001 anthrax attacks in the United States during her tenure as the acting deputy director of the National Center for Infectious Diseases, where she was a prominent spokeswoman for the CDC during daily briefings regarding the attacks and aftermath. Gerberding then served as CDC director from 2002-2009, and was then hired as an administrator at Merck.

GeoVax is a clinical-stage biotechnology company which develops vaccines. GeoVax’s development platform uses Modified Vaccinia Ankara (MVA) vector technology, with improvements to antigen design and manufacturing capabilities. GeoVax uses recombinant DNA or recombinant viruses to produce virus-like particles (VLPs) in the person being vaccinated.

<span class="mw-page-title-main">Seth Berkley</span> American medical epidemiologist

Seth Franklin Berkley is an American medical epidemiologist, the CEO of Gavi, the Vaccine Alliance and a global advocate of the power of vaccines. He is the founder and former president and CEO of the International AIDS Vaccine Initiative (IAVI).

<span class="mw-page-title-main">Vaccine Research Center</span>

The Vaccine Research Center (VRC), is an intramural division of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), US Department of Health and Human Services (HHS). The mission of the VRC is to discover and develop both vaccines and antibody-based products that target infectious diseases.

Vaccinia immune globulin (VIG) is made from the pooled blood of individuals who have been inoculated with the smallpox vaccine. The antibodies these individuals developed in response to the smallpox vaccine are removed and purified. This results in VIG. It can be administered intravenously. It is used to treat individuals who have developed progressive vaccinia after smallpox vaccination.

<span class="mw-page-title-main">Anne Searls De Groot</span> American immunologist

Anne Searls De Groot is a physician, immunologist and entrepreneur. She is the co-founder and CEO/CSO of the immunoinformatics company EpiVax. Prior to EpiVax, she was a professor at Brown University, where she established the TB/HIV Research Lab. The laboratory attracted a range of intelligent and creative Brown University undergraduate and graduate students who worked with De Groot on projects ranging from improving healthcare for inmates living in correctional facilities in the United States, improving access to care in West Africa, and developing cutting edge tools for analyzing protein sequences and designing vaccines.

<span class="mw-page-title-main">George Siber</span> Medical researcher and vaccine expert

George Rainer Siber is a medical researcher and vaccine expert with 47 years of experience in developing numerous vaccines, therapeutic antibodies, and diagnostic agents for infectious diseases.

Translational Health Science and Technology Institute (THSTI) is a society registered under the Societies Registration Act XXI of 1860. It is also an autonomous institute of the Department of Biotechnology, Ministry of Science and Technology, Government of India. It was set up in 2009 at Gurgaon and is now located in NCR Biotech Science Cluster, Faridabad along with the Regional Center for Biotechnology, Advanced Technology Platforms Center, Small Animal Facility, and Bio-incubator. Envisioned by former secretary of DBT, M. K. Bhan, the centre was created to enable faster transition of lab research to market. Pramod Garg is the executive director of THSTI.

M. Juliana “Julie” McElrath is a senior vice president and director of the vaccine and infectious disease division at Fred Hutchinson Cancer Research Center and the principal investigator of the HIV Vaccine Trials Network Laboratory Center in Seattle, Washington. She is also a professor at the University of Washington.

Carlos del Rio is a distinguished professor of medicine at Emory University School of Medicine. He is also a professor of global health and epidemiology at the Rollins School of Public Health of Emory University, executive associate dean of Emory University School of Medicine at Grady Health System and co-director of the Emory Center for AIDS Research. He is a member of the National Academy of Medicine and was elected as its foreign secretary in 2020. In 2022, del Rio became president of the Infectious Diseases Society of America.

Larry J. Anderson is an American virologist who served in leadership positions at the Centers for Disease Control and Prevention (CDC) for more than three decades. He was director of the Division of Viral Diseases in the National Center for Immunization and Respiratory Diseases at the CDC (2006–2010), and chief of the Respiratory and Enteric Viruses Branch of the CDC Division of Viral and Rickettsial Diseases (1982–2006). From 2003 to 2006, Anderson led the CDC’s Post-Outbreak SARS Program, and he served as a special advisor on smallpox in the Office of the Associate Director for Terrorism, Preparedness, and Response.

Marylyn Martina Addo is a German infectiologist who is a Professor and the German Center for Infection Research (DZIF) Head of Infectious Disease at the University Medical Center Hamburg-Eppendorf. Addo has developed and tested vaccinations that protect people from Ebola virus disease and the MERS coronavirus EMC/2012. She is currently developing a viral vector based COVID-19 vaccine.

<span class="mw-page-title-main">Rochelle Walensky</span> American medical scientist

Rochelle Paula Walensky is an American physician-scientist who is the director of the Centers for Disease Control and Prevention and the administrator of the Agency for Toxic Substances and Disease Registry. Prior to her appointment at the CDC, she was the Chief of the Division of Infectious Diseases at Massachusetts General Hospital and a professor of medicine at Harvard Medical School. Walensky is an expert on HIV/AIDS.

<span class="mw-page-title-main">Andrew Kambugu</span> Ugandan physician

Andrew Ddungu Kambugu is a Ugandan physician who serves as The Sande-McKinnell Executive Director at Uganda Infectious Disease Institute and a Honorary Senior lecturer at Makerere University College of Sciences. He is also an Adjunct Associate Professor at the University of Minnesota. In July 2020, he was appointed to the United Nations 2021 Food System Scientific Group.

References

  1. Karkaria, Urvaksh (December 21, 2012). "Emory's Hope Clinic expands near DeKalb Medical". Atlanta Business Chronicle. Retrieved June 15, 2014.
  2. "IDSA Honors Notable Leaders in Infectious Diseases at IDWeek 2022" (Press release). Infectious Diseases Society of America. October 19, 2022. Retrieved November 16, 2022.
  3. Gabel, Sam (August 28, 2012). "A Hopeful Future: The Emory Clinic Hope Project". David Atlanta. Archived from the original on August 8, 2014. Retrieved July 22, 2014.